ALVO
AlvotechNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.18B
P/E Ratio
37.90
EPS
$0.10
Beta
0.25
52W High
$11.85
52W Low
$3.03
50-Day MA
$4.22
200-Day MA
$6.51
Dividend Yield
—
Profit Margin
4.74%
Forward P/E
7.91
PEG Ratio
—
About Alvotech
Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.
Fundamentals
| Revenue (TTM) | $588.90M |
| Gross Profit (TTM) | $355.55M |
| EBITDA | $115.76M |
| Operating Margin | 30.90% |
| Return on Equity | 0.00% |
| Return on Assets | 3.60% |
| Revenue/Share (TTM) | $2.11 |
| Book Value | $-0.91 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 2.00 |
| EV/Revenue | 4.123 |
| EV/EBITDA | 7.77 |
| Quarterly Earnings Growth (YoY) | -58.40% |
| Quarterly Revenue Growth (YoY) | 10.10% |
| Shares Outstanding | $311.60M |
| Float | $114.08M |
| % Insiders | 62.57% |
| % Institutions | 6.05% |
Analyst Ratings
Consensus ($14.00 target)
1
Strong Buy3
Buy1
Hold1
Strong SellData last updated: 4/7/2026